Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena Boshoff

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Future Medicinal Chemistry|September 2, 2011
Nitroimidazoles for the treatment of TB: past, present and futureTathagata Mukherjee, Helena Boshoff
Nature Chemical Biology|January 13, 2006
Getting the iron outClifton E Barry, Helena Boshoff
The Journal of Antimicrobial Chemotherapy|October 11, 2011
Comment on: Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonaeTathagata Mukherjee, Helena Boshoff, Clifton E Barry
Journal of Biomolecular Screening|June 16, 2009
Dequalinium, a new inhibitor of Mycobacterium tuberculosis mycothiol ligase identified by high-throughput screeningMaria-Teresa Gutierrez-Lugo, Heather Baker, Joseph Shiloach, et al.
Journal of Bacteriology|September 6, 2006
Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulenceBrigitte Saint-Joanis, Caroline Demangel, Mary Jackson, et al.
Journal of Medicinal Chemistry|January 6, 2006
Rationally designed nucleoside antibiotics that inhibit siderophore biosynthesis of Mycobacterium tuberculosisRavindranadh V Somu, Helena Boshoff, Chunhua Qiao, et al.
Plos One|November 24, 2011
Rv2607 from Mycobacterium tuberculosis is a pyridoxine 5'-phosphate oxidase with unusual substrate specificityEllene H Mashalidis, Tathagata Mukherjee, Paweł Sledź, et al.
ACS Medicinal Chemistry Letters|June 22, 2011
Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis ActivityGarrett C Moraski, Lowell D Markley, Philip A Hipskind, et al.
JACS Au|February 28, 2025
A Systematic Approach to Discover New Natural Product Scaffolds Using Database-Derived Relative Mass Spectral Defects and Molecular NetworkingHyo Moon Cho, Eleonora Boccia, Rahim Rajwani, et al.
Antimicrobial Agents and Chemotherapy|December 6, 2017
Extreme Drug Tolerance of Mycobacterium tuberculosis in CaseumJansy P Sarathy, Laura E Via, Danielle Weiner, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Future Medicinal Chemistry|September 2, 2011
Nitroimidazoles for the treatment of TB: past, present and futureTathagata Mukherjee, Helena Boshoff
Nature Chemical Biology|January 13, 2006
Getting the iron outClifton E Barry, Helena Boshoff
The Journal of Antimicrobial Chemotherapy|October 11, 2011
Comment on: Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonaeTathagata Mukherjee, Helena Boshoff, Clifton E Barry
Journal of Biomolecular Screening|June 16, 2009
Dequalinium, a new inhibitor of Mycobacterium tuberculosis mycothiol ligase identified by high-throughput screeningMaria-Teresa Gutierrez-Lugo, Heather Baker, Joseph Shiloach, et al.
Journal of Bacteriology|September 6, 2006
Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulenceBrigitte Saint-Joanis, Caroline Demangel, Mary Jackson, et al.
Journal of Medicinal Chemistry|January 6, 2006
Rationally designed nucleoside antibiotics that inhibit siderophore biosynthesis of Mycobacterium tuberculosisRavindranadh V Somu, Helena Boshoff, Chunhua Qiao, et al.
Plos One|November 24, 2011
Rv2607 from Mycobacterium tuberculosis is a pyridoxine 5'-phosphate oxidase with unusual substrate specificityEllene H Mashalidis, Tathagata Mukherjee, Paweł Sledź, et al.
ACS Medicinal Chemistry Letters|June 22, 2011
Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis ActivityGarrett C Moraski, Lowell D Markley, Philip A Hipskind, et al.
JACS Au|February 28, 2025
A Systematic Approach to Discover New Natural Product Scaffolds Using Database-Derived Relative Mass Spectral Defects and Molecular NetworkingHyo Moon Cho, Eleonora Boccia, Rahim Rajwani, et al.
Antimicrobial Agents and Chemotherapy|December 6, 2017
Extreme Drug Tolerance of Mycobacterium tuberculosis in CaseumJansy P Sarathy, Laura E Via, Danielle Weiner, et al.
Pageof 2